P109: One‐Day Brentuximab‐Bendamustine (120mg/m2) every 21 days is a feasible and safe treatment for relapsed/refractory Hodgkin lymphoma von Moatti, Hannah, Laroque, Marie‐Céleste, Renaud, Loïc., Ravdan, Odonchimeg, Schmidt‐Hieber, Charlotte, Madelaine, Isabelle, Di Blasi, Roberta, Thieblemont, Catherine, Brice, Pauline

Volltext

Comprehensive Analysis of Mesenchymal Cells from Myeloproliferative Neoplasm (MPN) Patients Reveals the Role of HOXB7 in Myelofibrosis Induction von Ganesan, Saravanan, Awan-Toor, Sarah, Guidez, Fabien, Maslah, Nabih, Aoun, Celine, Gou, Panhong, Guiguen, Chloe, Soret, Juliette, Ravdan, Odonchimeg, Bisio, Valeria, Dulphy, Nicolas, Schlageter, Marie-Hélène, Souyri, Michele, Giraudier, Stephane, Kiladjian, Jean-Jacques, Chomienne, Christine, Cassinat, Bruno

Volltext

Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement von Maslah, Nabih, Ravdan, Odonchimeg, Drevon, Louis, Verger, Emmanuelle, Belkhodja, Célia, Chomienne, Christine, Cassinat, Bruno, Kiladjian, Jean‐Jacques, Giraudier, Stéphane, Schlageter, Marie‐Hélène

Volltext

Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/HOXB7 axis in patients with myelofibrosis von Ganesan, Saravanan, Awan-Toor, Sarah, Guidez, Fabien, Maslah, Nabih, Rahimy, Rifkath, Aoun, Céline, Gou, Panhong, Guiguen, Chloé, Soret, Juliette, Ravdan, Odonchimeg, Bisio, Valeria, Dulphy, Nicolas, Lobry, Camille, Schlageter, Marie-Hélène, Souyri, Michèle, Giraudier, Stéphane, Kiladjian, Jean-Jacques, Chomienne, Christine, Cassinat, Bruno

Volltext

L’arrivée de l’immunothérapie dans le lymphome de Hodgkin von Gilardin, Laurent, Amorim, Sandy, Bernard, Sophie, Ravdan, Odonchimeg, Thieblemont, Catherine, Brice, Pauline

Volltext